ftInvstr
VIMTALABS · Healthcare ₹638.7 -2.19% Mkt Cap ₹2856 Cr overvalued
← Search another stock

VIMTALABS

Healthcare Diagnostics & Research
★ Watchlist ⧉ Add to bucket
₹638.7
-2.19% today · 30d -0.51%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for VIMTALABS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2024-12-31
REVENUE
₹90 Cr
+10.09% YoY
NET PROFIT
₹21 Cr
+112.16% YoY
OPM
37.64%
+10.11pp YoY
EPS
₹7.86
PE 35.87
Intrinsic value · DCF ₹169.24 · Margin of safety -73.5% (overvalued) · FCF yield 1.03%
◇ Sector Position
PEERPEROCE %
VIMTALABS35.87—
SAILIFE93.1518.42
LALPATHLAB62.2931.74
SYNGENE72.0416.59
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
67
SCORE / 100
Overall
6-axis composite of the sections below.
Performance POSITIVE 55
Valuation FAIR 40
Growth STRONG 80
Profitability HIGH 90
Technicals NEUTRAL 67
Risk LOW 70
Key Stats
TTM PE
35.87
P/B
6.26
52W HIGH
₹902.65
OFF HIGH
-29.24%
DIV YIELD
0.31%
MKT CAP
₹2856 Cr
◉ Active Signals
MACDNeutral-0.1068
RSI(14)Neutral53.78
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold VIMTALABS and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.